3 documents found, page 1 of 1
Chapter 7 - Ethical issues in research and development of nanoparticles
Souto, Eliana B.; Dias-Ferreira, João; Shegokar, Ranjita; Durazzo, Alessandra; Santini, AntonelloCurrent societal challenges demonstrate the added value of nanotechnology in improving several goods in a set of industries (e.g., pharmaceuticals, nutraceuticals, cosmetics, medical devices). Along with the unprecedent technological developments, ethical issues are posed to scientists, regulators, and users as new materials with new functionalities are being launched that have unforeseen impact in the society....
Bioactive hybrid nanowires: a new in trend for site-specific drug delivery and ...
Fernandes, A. R.; Dias-Ferreira, J.; Teixeira, M. C.; Shimojo, A. A. M.; Severino, Patrícia; Silva, A. M.; Shegokar, Ranjita; Souto, Eliana B.The current progress of modern medicine is based on the resistance of malignant tumors in advanced medical treatments, as well as on the need to develop new therapeutic approaches. In the last few years, numerous studies have focused their attention on the promising use of nanomaterials, such as nanowires, zinc oxide, or mesoporous silica nanoparticles, among others. All these particles are studied in the treat...
Chapter 1 - Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism...
Campos, J. R.; Severino, P.; Santini, A.; Silva, A. M.; Shegokar, Ranjita; Souto, S. B.; Souto, Eliana B.Various controlled delivery systems have been promoted in the recent decades in order to improve solubility, stability as well as bioavailability of poorly absorbed drugs. Solid lipidic nanoparticles (SLNs) are made of solid lipid matrix and a surfactant layer, and they have as characteristics the fact that can load poorly water-soluble drugs, delivering them at defined rates and thus enhancing their intracellu...